Crispr Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $17M | 257k | 64.81 |
| 2025-03-31 | $5.0M | 147k | 34.03 |
| 2024-12-31 | $7.8M | 197k | 39.36 |
| 2024-09-30 | $9.9M | 210k | 46.98 |
| 2024-06-30 | $14M | 265k | 54.01 |
| 2024-03-31 | $9.6M | 140k | 68.16 |
| 2023-12-31 | $14M | 217k | 62.60 |
| 2023-09-30 | $8.9M | 195k | 45.39 |
| 2023-06-30 | $12M | 209k | 56.14 |
| 2023-03-31 | $14M | 309k | 45.23 |
| 2022-12-31 | $27M | 664k | 40.65 |
| 2022-06-30 | $39M | 639k | 60.77 |
| 2022-03-31 | $7.3M | 117k | 62.77 |
| 2021-12-31 | $18M | 234k | 75.78 |
| 2021-09-30 | $37M | 328k | 111.93 |
| 2021-03-31 | $14M | 114k | 121.85 |
| 2020-12-31 | $19M | 125k | 153.11 |
| 2020-09-30 | $6.4M | 77k | 83.64 |
| 2020-06-30 | $8.1M | 110k | 73.49 |
| 2019-12-31 | $10M | 164k | 60.92 |
| 2019-09-30 | $2.3M | 56k | 40.99 |
| 2019-06-30 | $2.4M | 51k | 47.11 |
| 2019-03-31 | $1.5M | 42k | 35.74 |
| 2018-12-31 | $1.5M | 52k | 28.56 |
| 2018-09-30 | $2.2M | 51k | 44.35 |
| 2018-06-30 | $3.1M | 54k | 58.75 |
| 2018-03-31 | $1.3M | 28k | 45.72 |
| 2017-12-31 | $532k | 23k | 23.47 |